Real-time enrollment status for this eosinophilic gastritis clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05831176 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Eosinophilic Gastritis |
| Phase | Clinical Trial |
| Target Enrollment | 22 participants |
| Active Locations | 53 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | October 8, 2025 (Oct 8, 2025) |
As of March 2, 2026: Clinical trial NCT05831176 is currently active_not_recruiting participants. This clinical trial study for eosinophilic gastritis is not currently accepting new participants at 53 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05831176 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 53 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05831176 was last updated Oct 8, 2025 (October 8, 2025). HelloStudys verifies this status automatically.